Direct evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis

dc.contributor.authorAgustín Ciapponi
dc.contributor.authorFabiana Barreira
dc.contributor.authorLucas Perelli
dc.contributor.authorAriel Bardach
dc.contributor.authorJoaquím Gascón
dc.contributor.authorIsrael Molina
dc.contributor.authorCarlos A. Morillo
dc.contributor.authorNilda Graciela Prado
dc.contributor.authorAdelina Riarte
dc.contributor.authorFaustino Torrico
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:04:43Z
dc.date.available2026-03-22T21:04:43Z
dc.date.issued2022
dc.descriptionCitaciones: 10
dc.description.abstractThe study protocol was registered in PROSPERO (CRD42019120905).
dc.identifier.doi10.1111/tmi.13831
dc.identifier.urihttps://doi.org/10.1111/tmi.13831
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85798
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofTropical Medicine & International Health
dc.sourceConsejo Nacional de Investigaciones Científicas y Técnicas
dc.subjectMedicine
dc.subjectBenznidazole
dc.subjectMeta-analysis
dc.subjectOdds ratio
dc.subjectPlacebo
dc.subjectInternal medicine
dc.subjectMEDLINE
dc.subjectSubgroup analysis
dc.subjectRandomized controlled trial
dc.subjectConfidence interval
dc.titleDirect evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis
dc.typereview

Files